Ovagen — EU research guide.
Ovagen is a Khavinson-series peptide bioregulator derived from liver tissue extract, proposed to support hepatocyte gene expression and liver cell regeneration. Unlike Livagen — its synthetic tetrapeptide counterpart in the same research family — Ovagen is a natural tissue complex without one single defined sequence.
What is Ovagen?
Ovagen is a Khavinson-series peptide bioregulator derived from liver tissue extract, proposed to support hepatocyte gene expression and liver cell regeneration. Unlike Livagen — its synthetic tetrapeptide counterpart in the same research family — Ovagen is a natural tissue complex without one single defined sequence.
What does the research show?
Published data is limited to small Eastern European cohort and animal studies on liver regeneration markers. Independent replication outside the originating research group is minimal as of mid-2026.
EU legal status
Not approved as a medicine anywhere in the EU. Available only from a small number of specialist research vendors.
Molecular information
Pharmacokinetics
Ovagen is not yet in our price comparison
We expand EU supplier coverage every month.